Frank Bennett

3.4k total citations
75 papers, 2.0k citations indexed

About

Frank Bennett is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Frank Bennett has authored 75 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 19 papers in Organic Chemistry and 14 papers in Infectious Diseases. Recurrent topics in Frank Bennett's work include Hepatitis C virus research (13 papers), HIV/AIDS drug development and treatment (12 papers) and Genetic Neurodegenerative Diseases (10 papers). Frank Bennett is often cited by papers focused on Hepatitis C virus research (13 papers), HIV/AIDS drug development and treatment (12 papers) and Genetic Neurodegenerative Diseases (10 papers). Frank Bennett collaborates with scholars based in United States, United Kingdom and Canada. Frank Bennett's co-authors include David W. Knight, John C. Reed, Garry Fenton, Juan M. Zapata, Irene M. Pedersen, Thomas J. Kipps, Shinichi Kitada, Jeffrey M. Trent, Mary J.C. Hendrix and Lawrence Stennett and has published in prestigious journals such as The Lancet, Journal of the American Chemical Society and Blood.

In The Last Decade

Frank Bennett

68 papers receiving 1.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Frank Bennett 1.2k 397 322 272 251 75 2.0k
Johannes Roesel 1.5k 1.3× 255 0.6× 337 1.0× 419 1.5× 198 0.8× 36 2.8k
Jinyun Dong 1.1k 0.9× 479 1.2× 182 0.6× 733 2.7× 209 0.8× 65 2.1k
Paul Nimmer 1.8k 1.5× 222 0.6× 274 0.9× 665 2.4× 315 1.3× 11 2.4k
Emmanuelle J. Meuillet 1.7k 1.4× 331 0.8× 133 0.4× 334 1.2× 288 1.1× 65 2.4k
Carlo M. Croce 2.4k 2.0× 599 1.5× 495 1.5× 607 2.2× 604 2.4× 31 3.6k
Kevin J. Duffy 690 0.6× 348 0.9× 152 0.5× 182 0.7× 132 0.5× 46 2.0k
Sabina Cosulich 2.0k 1.7× 158 0.4× 188 0.6× 526 1.9× 253 1.0× 55 2.6k
Christian Billard 984 0.8× 106 0.3× 405 1.3× 425 1.6× 547 2.2× 66 2.0k
David M. Ryckman 1.3k 1.1× 423 1.1× 99 0.3× 413 1.5× 83 0.3× 31 1.8k
Mamoru Shoji 1.8k 1.6× 371 0.9× 168 0.5× 493 1.8× 163 0.6× 63 3.0k

Countries citing papers authored by Frank Bennett

Since Specialization
Citations

This map shows the geographic impact of Frank Bennett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Bennett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Bennett more than expected).

Fields of papers citing papers by Frank Bennett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Bennett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Bennett. The network helps show where Frank Bennett may publish in the future.

Co-authorship network of co-authors of Frank Bennett

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Bennett. A scholar is included among the top collaborators of Frank Bennett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Bennett. Frank Bennett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benatar, Michael, Lyle W. Ostrow, Joseph W. Lewcock, et al.. (2023). Biomarker Qualification for Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: Theory and Practice. Annals of Neurology. 95(2). 211–216. 13 indexed citations
2.
Rothstein, Jeffrey D., Paymaan Jafar‐Nejad, Frank Rigo, et al.. (2023). G2C4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neurons. Acta Neuropathologica. 147(1). 1–1. 12 indexed citations
3.
Jauvin, Dominic, Frank Bennett, Frank Rigo, et al.. (2022). Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting Dystrophia Myotonica Protein Kinase Transcripts for the Treatment of Myotonic Dystrophy Type 1. Human Gene Therapy. 33(15-16). 810–820. 16 indexed citations
4.
Reilly, Sean W., Frank Bennett, Patrick S. Fier, Sumei Ren, & Neil A. Strotman. (2020). Late‐Stage 18 O Labeling of Primary Sulfonamides via a Degradation–Reconstruction Pathway. Chemistry - A European Journal. 26(19). 4251–4255. 11 indexed citations
5.
Gertsman, Ilya, Joanne Wuu, Melissa McAlonis‐Downes, et al.. (2019). An endogenous peptide marker differentiates SOD1 stability and facilitates pharmacodynamic monitoring in SOD1 amyotrophic lateral sclerosis. JCI Insight. 4(10). 15 indexed citations
6.
Montes, Jacqueline, Sally Dunaway Young, Elena Mazzone, et al.. (2018). Ambulatory function and fatigue in nusinersen-treated children with spinal muscular atrophy. (P2.322). Neurology. 90(15_supplement). 4 indexed citations
7.
Glanzman, Allan M., Elena Mazzone, Sally Dunaway Young, et al.. (2017). Reliability of functional outcome measures in spinal muscular atrophy: Results from multi-centered, global, phase 3 clinical trials (S13.004). Neurology. 88(16_supplement).
8.
Bennett, Frank, Alexei V. Buevich, Hsueh‐Cheng Huang, et al.. (2017). Concise syntheses and HCV NS5B polymerase inhibition of (2′R)-3 and (2′S)-2′-ethynyluridine-10 and related nucleosides. Bioorganic & Medicinal Chemistry Letters. 27(23). 5349–5352. 2 indexed citations
9.
Finkel, Richard S., Claudia A. Chiriboga, Jiri Vajsar, et al.. (2016). Interim Results of a Phase 2 Clinical Study of Nusinersen (ISIS-SMNRx) in Patients with Infantile-Onset Spinal Muscular Atrophy (P5.004). Neurology. 86(16_supplement). 5 indexed citations
10.
Finkel, Richard S., John Day, Claudia A. Chiriboga, et al.. (2014). Results of a Phase 2 Open-Label Study of ISIS-SMNRx in Patients with Infantile (Type 1) Spinal Muscular Atrophy (S6.003). Neurology. 82(10_supplement). 8 indexed citations
11.
Scoles, Daniel R., Gene Hung, Lance Pflieger, et al.. (2014). Treatment Of Spinocerebellar Ataxia Type 2 (SCA2) with MOE Antisense Oligonucleotides (S47.006). Neurology. 82(10_supplement). 1 indexed citations
12.
Hung, Gene, Kurt Giles, Chris Black, et al.. (2012). Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice. Molecular Therapy — Nucleic Acids. 1. e9–e9. 36 indexed citations
13.
Geary, Richard S., John Matson, Megan Pearce, et al.. (2009). Effect of dose and plasma concentration on liver uptake and pharmacologic activity of a 2′-methoxyethyl modified chimeric antisense oligonucleotide targeting PTEN. Biochemical Pharmacology. 78(3). 284–291. 66 indexed citations
14.
Venkatraman, Srikanth, Wanli Wu, Latha G. Nair, et al.. (2009). Discovery of novel P3 sulfonamide-capped inhibitors of HCV NS3 protease. Inhibitors with improved cellular potencies. Bioorganic & Medicinal Chemistry. 17(13). 4486–4495. 7 indexed citations
15.
Qin, Jian‐Zhong, Lawrence Stennett, Barbara Bodner, et al.. (2005). Proteasome Inhibitors Trigger NOXA-Mediated Apoptosis in Melanoma and Myeloma Cells. Cancer Research. 65(14). 6282–6293. 263 indexed citations
16.
Bennett, Frank, Yi‐Tsung Liu, Anil K. Saksena, et al.. (2005). Novel inhibitors of the hepatitis C virus NS3 proteinase. Bioorganic & Medicinal Chemistry Letters. 15(19). 4275–4278. 2 indexed citations
17.
Feng, Wenqing, Haiying Liu, Guodong Chen, et al.. (2001). Structural characterization of the oxidative degradation products of an antifungal agent SCH 56592 by LC–NMR and LC–MS. Journal of Pharmaceutical and Biomedical Analysis. 25(3-4). 545–557. 32 indexed citations
18.
Chen, Jun, Wei Wu, Stephen K. Tahir, et al.. (2000). Down-regulation of Survivin by Antisense Oligonucleotides Increases Apoptosis, Inhibits Cytokinesis and Anchorage-Independent Growth. Neoplasia. 2(3). 235–241. 169 indexed citations
19.
Bennett, Frank, et al.. (1998). Novel HIV- protease inhibitors containing β-hydroxyether and -thioether dipeptide isostere surrogates: modification of the P3 ligand. Bioorganic & Medicinal Chemistry Letters. 8(8). 931–934.
20.
Girijavallabhan, Viyyoor, Frank Bennett, Ashit K. Ganguly, et al.. (1994). The synthesis of novel HIV-protease inhibitors. Bioorganic & Medicinal Chemistry. 2(10). 1075–1083. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johannes Roesel Breakdown of academic impact, for papers by Jinyun Dong Breakdown of academic impact, for papers by Paul Nimmer Breakdown of academic impact, for papers by Emmanuelle J. Meuillet Breakdown of academic impact, for papers by Carlo M. Croce Breakdown of academic impact, for papers by Kevin J. Duffy Breakdown of academic impact, for papers by Sabina Cosulich Breakdown of academic impact, for papers by Christian Billard Breakdown of academic impact, for papers by David M. Ryckman Breakdown of academic impact, for papers by Mamoru Shoji
Rankless by CCL
2026